Carnitine regulates myocardial metabolism by peroxisome proliferator-activated receptor-α (PPARα) in alcoholic cardiomyopathy

Medical Science Monitor

Volumn 17, Issue 1, 2011, Pages

  Jing, Ling ^a   Zhou, Li Jun ^a   Li, Wei min ^a   Zhang, Feng min ^a   Yuan, Lin ^a   Li, Shuang ^b   Song, Jian ^a   Sang, Ying ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b Jiamusi Medical University   (China)

Author keywords

Alcoholic cardiomyopathy; Carnitine; Mechanism; Metabolism; Structural remodeling

Indexed keywords

ADENINE NUCLEOTIDE TRANSLOCASE; ADENOSINE TRIPHOSPHATASE; ALCOHOL; CARNITINE; CARNITINE PALMITOYLTRANSFERASE I; FATTY ACID; MEDIUM CHAIN ACYL COENZYME A DEHYDROGENASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; ACYL COENZYME A DEHYDROGENASE; ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; CARNITINE PALMITOYLTRANSFERASE; PHOSPHATE;

ALCOHOL CONSUMPTION; ALCOHOLIC CARDIOMYOPATHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ENZYME ACTIVITY; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE METABOLISM; MALE; NONHUMAN; PROTEIN TRANSPORT; RAT; ANIMAL; BLOOD; ELECTRON MICROSCOPY; HEART MUSCLE; METABOLISM; ULTRASTRUCTURE;

ACYL-COA DEHYDROGENASE; ADENINE NUCLEOTIDE TRANSLOCATOR 1; ADENOSINE DIPHOSPHATE; ADENOSINE MONOPHOSPHATE; ADENOSINE TRIPHOSPHATASES; ADENOSINE TRIPHOSPHATE; ANIMALS; CARDIOMYOPATHY, ALCOHOLIC; CARNITINE; CARNITINE O-PALMITOYLTRANSFERASE; ETHANOL; FATTY ACIDS, NONESTERIFIED; MICROSCOPY, ELECTRON; MYOCARDIUM; PHOSPHATES; PPAR ALPHA; RATS;

EID: 78651364560     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.881311     Document Type: Article

References (39)

1. Piano MR: Alcoholic cardiomyopathy: incidence, clinical characteristics, and pathophysiology. Chest, 2002; 121: 1638-50
2. Van Camp G: Toxic cardiopathies. Acta Clinica Belgica, 2005; 60: 293-300
3. De Keulenaer GW, Brutsaert DL: Dilated cardiomyopathies: changing pathophysiological concepts and mechanisms of dysfunction. J Card Surg, 1999; 14: 64-74
4. Konstam MA, Dracup K, Baker DW et al: Heart failure: evaluation and care of patients with left ventricular systolic dysfunction. J Card Fail, 1995: 183-87
5. Packer M, Cohn JN, Abraham WT: Consensus recommendations for the management of chronic heart failure. Am J Cardiol, 1999; 83: 1A-38A
6. Li SY, Ren J: Cardiac overexpression of alcohol dehydrogenase exacerbates chronic ethanol ingestion-induced myocardial dysfunction and hypertrophy: role of insulin signaling and ER stress. J Mol Cell Cardiol, 2008; 44: 992-1001
7. Takahashi R, Asai T, Murakami H et al: Pressure overload - Induced cardiomyopathy in heterozygous carrier mice of carnitine transporter gene mutation. Hypertension, 2007; 50: 497-502
8. Steiber A, Kerner J, Hoppel CL: Carnitine: a nutritional, biosynthetic, and functional perspective. Mol. Aspects Med, 2004; 25: 455-73
9. Hothi DK, Geary DF, Fisher L et al: Short-term effects of nocturnal haemodialysis on carnitine metabolism. Nephrol Dial Transplant, 2006; 21: 2637-41
10. Stephens FB, Constantin-Teodosiu D, Greenhaff PL: New insights concerning the role of carnitine in the regulation of fuel metabolism in skeletal muscle. J Physiol, 2007; 581: 431-44
11. Fontanive P, Saponati G, Iurato A et al, L-Arginine in Heart Failure Study Group: Effects of L-arginine on the Minnesota Living with Heart Failure Questionnaire quality-of-life score in patients with chronic systolic heart failure. Med Sci Monit, 2009; 15(12): CR606-11
12. Nixon M: A simple and sensitive colorimetric method for the determination of long-chain free fatty acids in subcelluar or ganelles. Anal Biochem, 1979; 97: 403-9.
13. Wan L, Hubbard RW: Determination of free and total carnitine with a random access chemistry analyzer. Clin Chem, 1998; 44: 8102-6
14. Zydowo MM, Swierczynski J, Nagel G: The respiration and calcium content of heart mitochondria from rats with vitamin D-induced cardionecrosis. Biochem J, 1985; 226: 155-61
15. Florian V, Schonfeld P: Alteration of the ADP/ATP translocase isoform pattern improves ATP expenditure in developing rat liver mitochondria. FEBS Lett, 1998; 433: 261-64
16. Schonfeld P, Bohnensack R: Developmental changes of the adenine nucleotide translocation in rat brain. Biochim Biophys Acta, 1995; 1232: 75-80
17. Schonfeld P, Schild L, Bohnensack R: Expression of the ADP/ATP carrier and expansion of the mitochondrial (ATP+ADP) pool contribute to postnatal maturation of the rat heart. Eur J Biochem, 1996; 241: 895-900
18. Monk BC, Kellerman GM: A rapid method for the assay of mitochondrial ATPase activity. Analytical Biochemistry, 1976; 73: 187-91
19. Kozlovski IV: Early and progressing alcohol cardiomyopathy. Klin Med, 2007; 85: 51-54
20. Skotzko CE, Vrinceanu A, Krueger L et al: Alcohol use and congestive heart failure: incidence, importance, and approaches to improved history taking. Heart Failure Reviews, 2007; 22: 43-46
21. De Vivo DC, Bohan TP, Coulter DL et al: L-Carnitine supplementation in childhood epilepsy: current perspectives. Epilepsia, 1998; 39: 1216-25
22. Rosenblatt-Velin N, Montessuit C, Papageorgiou I et al: Postinfarction heart failure in rats is associated with upregulation of GLUT-1 and downregulation of genes of fatty acid metabolism. Cardiovasc Res, 2001; 52: 407-16
23. Zhai P, Gao S, Holle E et al: Glycogen synthase kinase-3 reduces cardiac growth and pressure overload induced cardiac hypertrophy by inhibition of extracellular signal-regulated kinases. J Biol Chem, 2007; 45: 33181-91
24. Berger J, Moller DE: The mechanisms of action of PPARs. Annu Rev Med, 2002; 53: 409-35
25. Feige JN, Gelman L, Michalik L et al: From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions. Prog Lipid Res, 2006; 45: 120-59
26. Barger PM, Brandt JM, Leone TC et al: Deactivation of peroxisome proliferator- activated receptor-alpha during cardiac hypertrophic growth. J Clin Invest, 2000; 105: 1723-30
27. Finck BN, Han X, Courtois M et al: A critical role for PPARalphamediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation by dietary fat content. Proc Natl Acad Sci USA, 2003; 100: 1226-31
28. Olpin SE: Fatty acid oxidation defects as a cause of neuromyopathic disease in infants and adults. Clin Lab, 2005; 51: 289-306
29. Calabrese V, Giuffrida Stella AM, Calvani M et al: Acetylcarnitine and cellular stress response: roles in nutritional redox homeostasis and regulation of longevity genes. J Nutri Biochem, 2006; 17: 73-88
30. 2+ in heart mitochondria. Syst Biol(Stevenage), 2006; 153: 350-53
31. Chen C, Saxena AK, Simcoke WN et al: Mitochondrial ATP synthase. crystal structure of the catalytic F1 unit in a vanadate-induced transition- like state and implications for mechanism. J Biol Chem, 2006; 281: 13777-83
32. Zharova TV, Vinogradov AD: Requirement of medium ADP for the steady-state hydrolysis of ATP by the proton-translocating Paracoccus denitrificans Fo.F1-ATP synthase. Biochim Biophys Acta, 2006; 1757: 304-10
33. Zhou Z, Sun X, Kang YJ: Ethanol-induced apoptosis in mouse liver: Fasand cytochrome c-mediated caspase-3 activation pathway. Am J Pathol, 2001; 159: 329-38
34. Zhou Z, Sun X, James Kang Y: Metallothionein protection against alcoholic liver injury through inhibition of oxidative Stress. Exp Biol Med, 2002; 227: 214-22
35. Zhou Z, Wang L, Song Z et al: A critical involvement of oxidative stress in acute alcohol-induced hepatic TNF-a production. Am J Pathol, 2003; 163: 1137-46
36. Kannan M, Wang L, Kang YJ: Myocardial oxidative stress and toxicity induced by acute ethanol exposure in mice. Exp Biol Med, 2004; 229: 553-59
37. Doser TA, Turdi S, Thomas DP et al: Transgenic overexpression of aldehyde dehydrogenase-2 rescues chronic alcohol intake-induced myocardial hypertrophy and contractile dysfunction. Circulation, 2009; 119: 1941-49
38. Li SY, Li Q, Shen JJ, Dong F et al: Attenuation of acetaldehyde-induced cell injury by overexpression of aldehyde dehydrogenase-2 (ALDH2) transgene in human cardiac myocytes: role of MAP kinase signaling. J Mol Cell Cardiol, 2006; 40: 283-94
39. Zhang X, Li SY, Brown RA, Ren J: Ethanol and acetaldehyde in alcoholic cardiomyopathy: from bad to ugly en route to oxidative stress. Alcohol, 2004; 437: 175-86